Cargando…
Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665249/ https://www.ncbi.nlm.nih.gov/pubmed/33204999 http://dx.doi.org/10.1097/HS9.0000000000000489 |
| _version_ | 1783609983184666624 |
|---|---|
| author | Lukes, Julius Winkowska, Lucie Zwyrtkova, Martina Starkova, Julia Sramkova, Lucie Stary, Jan Trka, Jan Zuna, Jan Zaliova, Marketa |
| author_facet | Lukes, Julius Winkowska, Lucie Zwyrtkova, Martina Starkova, Julia Sramkova, Lucie Stary, Jan Trka, Jan Zuna, Jan Zaliova, Marketa |
| author_sort | Lukes, Julius |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7665249 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76652492020-11-16 Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 Lukes, Julius Winkowska, Lucie Zwyrtkova, Martina Starkova, Julia Sramkova, Lucie Stary, Jan Trka, Jan Zuna, Jan Zaliova, Marketa Hemasphere Letter Lippincott Williams & Wilkins 2020-11-10 /pmc/articles/PMC7665249/ /pubmed/33204999 http://dx.doi.org/10.1097/HS9.0000000000000489 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Letter Lukes, Julius Winkowska, Lucie Zwyrtkova, Martina Starkova, Julia Sramkova, Lucie Stary, Jan Trka, Jan Zuna, Jan Zaliova, Marketa Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title | Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title_full | Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title_fullStr | Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title_full_unstemmed | Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title_short | Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1 |
| title_sort | identification of fusion gene breakpoints is feasible and facilitates accurate sensitive minimal residual disease monitoring on genomic level in patients with pml-rara, cbfb-myh11, and runx1-runx1t1 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665249/ https://www.ncbi.nlm.nih.gov/pubmed/33204999 http://dx.doi.org/10.1097/HS9.0000000000000489 |
| work_keys_str_mv | AT lukesjulius identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT winkowskalucie identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT zwyrtkovamartina identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT starkovajulia identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT sramkovalucie identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT staryjan identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT trkajan identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT zunajan identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 AT zaliovamarketa identificationoffusiongenebreakpointsisfeasibleandfacilitatesaccuratesensitiveminimalresidualdiseasemonitoringongenomiclevelinpatientswithpmlraracbfbmyh11andrunx1runx1t1 |